282 related articles for article (PubMed ID: 17909206)
1. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.
Alvaro D; Macarri G; Mancino MG; Marzioni M; Bragazzi M; Onori P; Corradini SG; Invernizzi P; Franchitto A; Attili AF; Gaudio E; Benedetti A
Ann Intern Med; 2007 Oct; 147(7):451-9. PubMed ID: 17909206
[TBL] [Abstract][Full Text] [Related]
2. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions.
Abdel-Razik A; ElMahdy Y; Hanafy EE; Elhelaly R; Elzehery R; M Tawfik A; Eldars W
Am J Med Sci; 2016 Mar; 351(3):259-64. PubMed ID: 26992254
[TBL] [Abstract][Full Text] [Related]
3. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.
Navaneethan U; Gutierrez NG; Jegadeesan R; Venkatesh PG; Poptic E; Liu X; Sanaka MR; Jang S; Vargo JJ; Parsi MA
Dig Dis Sci; 2013 Oct; 58(10):2986-92. PubMed ID: 23828141
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses.
Severino V; Dumonceau JM; Delhaye M; Moll S; Annessi-Ramseyer I; Robin X; Frossard JL; Farina A
Gastroenterology; 2017 Aug; 153(2):495-504.e8. PubMed ID: 28479376
[TBL] [Abstract][Full Text] [Related]
6. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study.
Weilert F; Bhat YM; Binmoeller KF; Kane S; Jaffee IM; Shaw RE; Cameron R; Hashimoto Y; Shah JN
Gastrointest Endosc; 2014 Jul; 80(1):97-104. PubMed ID: 24559784
[TBL] [Abstract][Full Text] [Related]
7. Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video).
Navaneethan U; Hasan MK; Kommaraju K; Zhu X; Hebert-Magee S; Hawes RH; Vargo JJ; Varadarajulu S; Parsi MA
Gastrointest Endosc; 2016 Oct; 84(4):649-55. PubMed ID: 26995690
[TBL] [Abstract][Full Text] [Related]
8. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Leelawat K; Sakchinabut S; Narong S; Wannaprasert J
BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942
[TBL] [Abstract][Full Text] [Related]
9. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
[TBL] [Abstract][Full Text] [Related]
10. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
[TBL] [Abstract][Full Text] [Related]
11. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study.
Navaneethan U; Parsi MA; Lourdusamy V; Bhatt A; Gutierrez NG; Grove D; Sanaka MR; Hammel JP; Stevens T; Vargo JJ; Dweik RA
Gastrointest Endosc; 2015 Apr; 81(4):943-9.e1. PubMed ID: 25500329
[TBL] [Abstract][Full Text] [Related]
12. Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma.
Lee SJ; Lee YS; Lee MG; Lee SH; Shin E; Hwang JH
Gut Liver; 2014 Nov; 8(6):669-73. PubMed ID: 25368755
[TBL] [Abstract][Full Text] [Related]
13. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
Farina A; Dumonceau JM; Antinori P; Annessi-Ramseyer I; Frossard JL; Hochstrasser DF; Delhaye M; Lescuyer P
Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
[TBL] [Abstract][Full Text] [Related]
15. Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction.
Beyazıt Y; Koçak E; Tanoğlu A
Turk J Gastroenterol; 2014 Oct; 25(5):592-3. PubMed ID: 25417631
[No Abstract] [Full Text] [Related]
16. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
Park MS; Kim TK; Kim KW; Park SW; Lee JK; Kim JS; Lee JH; Kim KA; Kim AY; Kim PN; Lee MG; Ha HK
Radiology; 2004 Oct; 233(1):234-40. PubMed ID: 15333766
[TBL] [Abstract][Full Text] [Related]
17. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
Chen CY; Lin XZ; Tsao HC; Shiesh SC
Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951
[TBL] [Abstract][Full Text] [Related]
18. MR cholangiopancreatography in malignant biliary obstruction.
Pavone P; Laghi A; Passariello R
Semin Ultrasound CT MR; 1999 Oct; 20(5):317-23. PubMed ID: 10527137
[TBL] [Abstract][Full Text] [Related]
19. Serum and bile biomarkers for cholangiocarcinoma.
Alvaro D
Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965
[TBL] [Abstract][Full Text] [Related]
20. Imaging techniques in patients with biliary obstruction.
Cieszanowski A; Chomicka D; Andrzejewska M; Pruszyński B; Pawlak J; Mustafa AM
Med Sci Monit; 2000; 6(6):1197-202. PubMed ID: 11208479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]